Group 1 - Otsuka Medical Devices Co., Ltd. has agreed to sell approximately 291 million shares of MicroPort Medical to various buyers, including Shanghai Shenshi Capital and We'Tron Capital Limited, which represents 15.7% of MicroPort's total share capital [1] - Following the announcement, MicroPort's stock price surged, opening up 14.99% and closing with a 4.75% increase, giving it a market capitalization of approximately HKD 21.2 billion [1] - This transaction will reduce Otsuka's stake in MicroPort from 20.7% to 5%, marking the first time since 2004 that Otsuka will not be the largest shareholder [1] Group 2 - Otsuka's initial investment in MicroPort dates back to 2004 when it invested USD 18 million for a 40% stake, which has since appreciated significantly, yielding a return of nearly 31 times [2] - The current shareholder structure of MicroPort includes We'Tron Capital Limited and the Jinshan Foundation as the second and third largest shareholders, holding a combined 37.5% [2] - The fourth and fifth largest shareholders are Shanghai ZJ Hi-Tech Investment Corporation and Shanghai Zhangjiang Health Products Holdings, with a combined stake of 16.0% [2] Group 3 - The buyer, Shanghai Shenshi Capital, is a fund management platform fully controlled by the Shanghai State-owned Assets Supervision and Administration Commission, indicating renewed interest in the biopharmaceutical sector [3] - MicroPort has faced financial challenges, reporting net losses over the past five years, with losses of CNY 1.248 billion, 1.763 billion, 3.04 billion, 3.383 billion, and 1.539 billion from 2020 to 2024 [3] - Despite the losses, MicroPort's revenue has shown consistent growth, increasing from CNY 4.233 billion in 2020 to CNY 7.412 billion in 2024 [3]
大冢控股“甩卖”微创医疗，上实资本“接盘”2.9亿股